2005
DOI: 10.1016/j.niox.2005.01.004
|View full text |Cite
|
Sign up to set email alerts
|

PGE2 enhances cytokine-elicited nitric oxide production in mouse cortical collecting duct cells

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
2
1
1

Citation Types

1
6
0

Year Published

2006
2006
2020
2020

Publication Types

Select...
6
2

Relationship

0
8

Authors

Journals

citations
Cited by 9 publications
(7 citation statements)
references
References 42 publications
1
6
0
Order By: Relevance
“…This finding is also in accordance with a series of our previous reports of defective NO and cGMP production in mPGES-1 null mice after highsalt loading or DOCA-salt treatment (22,24). Other investigations also suggest the potential of PGE 2 in stimulating NO and cGMP production in various renal or extrarenal systems (16,17,26,40). Overall, these results support the existence of PGE 2 /NO/cGMP pathway that appears to be important in renal salt handling.…”
Section: Discussionsupporting
confidence: 91%
“…This finding is also in accordance with a series of our previous reports of defective NO and cGMP production in mPGES-1 null mice after highsalt loading or DOCA-salt treatment (22,24). Other investigations also suggest the potential of PGE 2 in stimulating NO and cGMP production in various renal or extrarenal systems (16,17,26,40). Overall, these results support the existence of PGE 2 /NO/cGMP pathway that appears to be important in renal salt handling.…”
Section: Discussionsupporting
confidence: 91%
“…Further, studies have reported that PGE2 triggers the Th1 response by the enhanced production of IL-2 and IFN-␥, which culminated in higher IL-12 production in dendritic cells [63,64]. In addition, PGE2 is suggested to enhance NO production in various cell types including rat liver macrophages known as Kupffer cells, mouse cortical-collecting duct cells, or rat gastric mucosa or to up-regulate astrocytic iNOS expression under the proinflammatory environment [65][66][67][68][69]. These findings have suggested that PGE2 could act in a positive-feedback loop in triggering NO production, which in turn, modulates signaling cascades leading to regulation of critical cell-fate decisions associated with inflammation during hostmycobacteria interactions.…”
Section: Discussionmentioning
confidence: 99%
“…16,18 EP2 has also been localized to mouse CCD cells, 14 the rabbit CCD, 33 and the human connecting tubule, 20 but kidney EP2 localization in mouse, rabbit, and human CDs is not consistently found. 13,14,21,22,33 EP2 is also expressed in renomedullary interstitial cells. 33 EP2 couples to Gs and signals through the second messenger cAMP.…”
Section: Postobstructive Polyuriamentioning
confidence: 99%
“…Butaprost increased ser-256 phosphorylation of AQP2 in cortical tubule suspensions and increased apical membrane accumulation of AQP2 in rat kidney slices, 18 indicating that EP2 is expressed in the CD, which has previously been an issue of some debate. 13,14,16,[18][19][20][21][22][23] This notion was further strengthened by the finding that butaprost was able to decrease polyuria in a rat model of x-linked NDI. Together, EP2 and EP4 are potential candidates for mediating urinary concentration in conditions with absent V2R signaling, but whether they can act alongside VP to increase urine concentration remains unknown.…”
mentioning
confidence: 96%